Cargando…
Synthetic ditempolphosphatidylcholine liposome-like nanoparticles for anti-oxidative therapy of atherosclerosis
Atherosclerosis (AS), a chronic inflammatory disease, is the leading cause of death worldwide. Anti-oxidative therapy has been developed for AS therapy in light of the critical role of ROS in pathogenesis of AS, but current anti-oxidants have exhibited limited outcomes in the clinic. Herein, new ROS...
Autores principales: | Wang, Chunxiao, Zhao, Ruifu, Wang, Zhen, Xu, Tingting, Huang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230271/ https://www.ncbi.nlm.nih.gov/pubmed/37266511 http://dx.doi.org/10.1039/d3ra01822a |
Ejemplares similares
-
Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis
por: Wan, Jun, et al.
Publicado: (2023) -
Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis [Corrigendum]
Publicado: (2023) -
Amphiphilic nanoparticles generate curvature in lipid membranes and shape liposome–liposome interfaces
por: Lavagna, E., et al.
Publicado: (2021) -
Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment
por: He, Yonglong, et al.
Publicado: (2022) -
Fusogenic liposome-enhanced cytosolic delivery of magnetic nanoparticles
por: Chen, Fang, et al.
Publicado: (2021)